Corvalol 25 ml

Combined drug, the effect of which is due to the properties of its constituent substances. It has a sedative and antispasmodic effect. Facilitates the onset of natural sleep.

Ethyl ester of α-bromisovalerianic acid has a sedative (like valerian effect) and antispasmodic effect. Phenobarbital enhances the sedative effect of other components, helps reduce central nervous system excitation and facilitates the onset of sleep.

Peppermint oil has a reflex vasodilating and antispasmodic effect.

As a sedative and vasodilator in the following diseases: functional disorders of the cardiovascular system (cardialgia, sinus tachycardia, increased blood pressure);

insomnia (violation of falling asleep);

neurotic conditions;

vegetative lability;

irritability; hypochondriac syndrome.

As an antispasmodic: muscle spasm of the digestive tract (intestinal and biliary colic).

The appointment of the drug during pregnancy is possible only according to strict indications.

If it is necessary to prescribe the drug during the period of feeding, the question of stopping breastfeeding should be decided.

hypersensitivity; severe hepatic and / or renal failure; lactation (breastfeeding).

Drowsiness, dizziness, decreased ability to concentrate, allergic reactions.

With prolonged use - chronic bromine poisoning (depression, apathy, rhinitis, conjunctivitis, hemorrhagic diathesis, impaired coordination of movements);

drug dependence.

Drugs that depress the central nervous system enhance the effect.

Phenobarbital (an inducer of microsomal oxidation) can reduce the effectiveness of drugs metabolized in the liver (including coumarin derivatives, griseofulvin, corticosteroids, oral contraceptives); enhances the action of local anesthetic, analgesic and hypnotic drugs.

Dosage is set individually.

Adults are usually prescribed 15-30 drops 3 times a day before meals.

With tachycardia, a single dose may be increased to 40-50 drops. Children are prescribed up to 3-15 drops per day, depending on the age and clinical picture of the disease.

The duration of the drug is determined by the doctor individually.

Symptoms: CNS depression, nystagmus, ataxia, decreased blood pressure, agitation, chronic bromine intoxication (depression, apathy, rhinitis, conjunctivitis, hemorrhagic diathesis, impaired coordination of movements).

Treatment: symptomatic, with central nervous system depression - caffeine, niketamide.

During the treatment period, care must be taken when driving vehicles and engaging in other potentially dangerous activities that require an increased concentration of attention and speed of psychomotor reactions.

Drops for oral administration in the form of a clear liquid with a specific aromatic odor.